3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 1, 2007, Pages 23-30

  Osorio, Joseph A ^a,b,c   Ozturk Isik, Esin ^a,b   Xu, Duan ^a,b   Cha, Soonmee ^b   Chang, Susan ^b   Berger, Mitchel S ^b   Vigneron, Daniel B ^a,b   Nelson, Sarah J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCSF Radiology   (United States)

Author keywords

3 Tesla; Brain tumors; Magnetic resonance spectroscopy imaging; Phased array; Proton

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; LACTIC ACID DERIVATIVE; LIPID; N-ACETYLASPARTATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; MALE; PHASED ARRAY COIL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAXATION TIME; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; TUMOR LOCALIZATION; CASE CONTROL STUDY; INSTRUMENTATION; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROBABILITY; TIME;

ADULT; AGED; ASPARTIC ACID; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHOLINE; CREATINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LACTATES; LIPIDS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MARKOV CHAINS; MIDDLE AGED; TIME FACTORS;

EID: 34547765838     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20970     Document Type: Article

References (28)

1. Nelson SJ. Magnetic resonance spectroscopic imaging. Evaluating responses to therapy for gliomas. IEEE Eng Med Biol Mag 2004;23: 30-39.
2. McBride DQ, Miller BL, Nikas DL, et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 1995;44: 137-144.
3. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686.
4. Nelson SJ, Graves E, Pirzkall A, et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 2002;16:464-476.
5. Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed 1999;12:123-138.
6. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-325.
7. Preul MC, Caramanos Z, Leblanc R, Villemure JG, Arnold DL. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed 1998;11:192-200.
8. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001;22:604-612.
9. Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 2002;16:229-237.
10. Gonen O, Gruber S, Li BS, Mlynarik V, Moser E. Multivoxel 3D proton spectroscopy in the brain at 1.5 vs. 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol 2001;22: 1727-1731.
11. Gruber S, Mlynarik V, Moser E. High-resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy-matched voxel sizes. Magn Reson Med 2003;49:299-306.
12. Li Y, Osorio JA, Ozturk E, et al. Considerations in applying 3-D PRESS 1H MRSI for studies of patients with brain tumors at 3T relative to 1.5T. Magn Reson Imaging 2006;24:295-302.
13. Gruetter R, Weisdorf SA, Rajanayagan V, et al. Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 1998;135:260-264.
14. Hetherington HP, Pan JW, Chu WJ, Mason GF, Newcomer BR. Biological and clinical MRS at ultra-high field. NMR Biomed 1997; 10:360-371.
15. Jeun SS, Kim MC, Kim BS, et al. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy. Clin Imaging 2005;29:10-15.
16. Wald LL, Moyher SE, Day MR, Nelson SJ, Vigneron DB. Proton spectroscopic imaging of the human brain using phased array detectors. Magn Reson Med 1995:34:440-445.
17. Wright SM, Wald LL. Theory and application of array coils in MR spectroscopy. NMR Biomed 1997;10:394-410.
18. Xu D, Chen AP, Cunningham C, Osorio JA, Nelson SJ, Vigneron DB. Spectroscopic imaging of the brain with phased-array coils at 3.0 T. Magn Reson Imaging 2006;24:69-74.
19. Frayne R, Goodyear BG, Dickhoff P. Lauzon ML, Sevick RJ. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 2003;38:385-402.
20. Schwindt W, Kugel H, Bachmann R, et al. Magnetic resonance imaging protocols for examination of the neurocranium at 3 T. Eur Radiol 2003;13:2170-2179.
21. Kim DS, Garwood M. High-field magnetic resonance techniques for brain research. Curr Opin Neurobiol 2003;13:612-619.
22. Srinivasan R, Vigneron D, Sailasuta N, Hurd R, Nelson S. A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain. Magn Reson Imaging 2004;22:523-528.
23. Tran TK, Vigneron DB, Sailasuta N, et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 2000;43:23-33.
24. Nelson SJ. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2001;46:228-239.
25. Li X, Vigneron DB, Cha S, et al. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol 2005;26:760-769.
26. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
27. McKnight TR, Noworolski SM, Vigneron DB, Nelson SJ. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging 2001;13:167-177.
28. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001:45:765-769.